Former FDA cancer chief Pazdur says the agency should restructure
Richard Pazdur, who spent more than two decades leading the FDA’s cancer drug reviews, said the agency has a “golden opportunity” to restructure after being struck last year by the Trump administration’s reduction in force. ...
Richard Pazdur, former director for the FDA's Oncology Center of Excellence July 22, 2026 02:46 PM EDT ChinaPharmaFDA+ Former cancer chief Pazdur says FDA has 'golden opportunity' to kill CDER and restructure Nicole DeFeudis Senior Reporter Richard Pazdur, who spent more than two decades leading the FDA’s cancer drug reviews, said the agency has a “golden opportunity” to restructure after being … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that